Fund exposure record
XBI
SPDR S&P Biotech ETF
State Street · Biotech
Reported positions
106
Rows in current dataset
Holdings coverage
55.7%
low confidence
Holdings snapshot
2026-01-02
Retrieved 2026-01-02
Latest price
2026-10-07
Adjusted-close observation
This holdings file is partial. Percentages below retain their reported scale; missing weight is not redistributed across visible positions.
YTD
+23.33%
1 year
+45.52%
3Y annualized
+27.88%
5Y annualized
+4.06%
Volatility
+31.94%
Max drawdown
-63.89%
Adjusted-close observations. Historical period is limited to available common dates.
Largest reported holdings
| Symbol | Name | Reported weight |
|---|---|---|
| FOLD | FOLD | 1.44% |
| TVTX | TVTX | 1.40% |
| EXEL | EXEL | 1.35% |
| BMRN | BMRN | 1.34% |
| MRNA | MRNA | 1.34% |
| ROIV | ROIV | 1.33% |
| PCVX | PCVX | 1.31% |
| HALO | HALO | 1.30% |
| MDGL | MDGL | 1.30% |
| REGN | REGN | 1.29% |
| RYTM | RYTM | 1.28% |
| CYTK | CYTK | 1.27% |
| UTHR | UTHR | 1.27% |
| AMGN | AMGN | 1.26% |
| BBIO | BBIO | 1.26% |
| INCY | INCY | 1.26% |
| PTCT | PTCT | 1.26% |
| KRYS | KRYS | 1.25% |
| PRAX | PRAX | 1.25% |
| VRTX | VRTX | 1.24% |
Classified reported exposure
2.5% of fund weight maps to the current sector dictionary.
Unclassified53.2%
Healthcare2.5%
Risk calculation details
- Sharpe ratio
- 0.15
- Sortino ratio
- 0.15
- Beta vs SPY
- 1.12
- CAPM alpha
- -7.81%
Calculated from date-aligned daily adjusted-close returns with a 4% annual risk-free assumption. Descriptive, not predictive.